Jun 27, 2023 / 08:00PM GMT
Operator
Good afternoon. And welcome to the Fusion Pharmaceuticals announces FPI-1434 Interim Phase I data conference call. (Operator Instructions) Please note that this event is being recorded. I would now like to turn the conference over to Amanda Cray, Head of Investor Relations. Please go ahead.
Amanda Cray - Fusion Pharmaceuticals Inc. - Senior Director of IR & Corporate Communications
Thank you, Megan. And thank you all for joining today's call. Please note that we have slides we'll be referring to posted in the Events and Presentations section of the Fusion website. With us from management on the call today are Chief Executive Officer, John Valliant; Chief Financial Officer, John Crowley; Chief Medical Officer, Dmitri Bobilev; Chief Technology Officer, Eric Burak; Chief Scientific Officer, Chris Leamon; and President and Chief Business Officer, Mohit Rawat. After our prepared remarks, we'll open the call for questions.
During today's call, we will be making a number of forward-looking statements based on current beliefs and expectations. Our actual
Fusion Pharmaceuticals Inc To Present Interim Data Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot